NCT04115566 Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
| NCT ID | NCT04115566 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Hidradenitis Suppurativa |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2020-08-01 |
| Primary Completion | 2035-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2020-08-01 with a primary completion date of 2035-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Eligibility Criteria
Inclusion Criteria: 1. Male or female ≥ 10 years of age 2. Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS 3. Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study. Exclusion Criteria: 1\. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.
Contact & Investigator
Haley B Naik, MD, MHSc, FAAD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT04115566 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, studying Hidradenitis Suppurativa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04115566 currently recruiting?
Yes, NCT04115566 is actively recruiting participants. Contact the research team at hsprogress@ucsf.edu for enrollment information.
Where is the NCT04115566 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT04115566 clinical trial?
NCT04115566 is sponsored by University of California, San Francisco. The principal investigator is Haley B Naik, MD, MHSc, FAAD at University of California, San Francisco. The trial plans to enroll 3,000 participants.